Changes in affect variability after starting gender-affirming hormone therapy
View ORCID ProfileMargot W. L. Morssinkhof, Marijn Schipper, View ORCID ProfileBaudewijntje P. C. Kreukels, Karin van der Tuuk, View ORCID ProfileMartin den Heijer, View ORCID ProfileOdile A. van den Heuvel, View ORCID ProfileDavid Matthew Doyle, View ORCID ProfileBirit F. P. Broekman
doi: https://doi.org/10.1101/2024.08.28.24312697
Margot W. L. Morssinkhof
1Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands
2Center of Expertise on Gender Dysphoria, Amsterdam UMC, Amsterdam, the Netherlands
Marijn Schipper
3Department of Psychiatry and Medical Psychology, OLVG Hospital, Amsterdam, the Netherlands
Baudewijntje P. C. Kreukels
1Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands
2Center of Expertise on Gender Dysphoria, Amsterdam UMC, Amsterdam, the Netherlands
Karin van der Tuuk
4Department of Obstetrics and Gynecology, University Medical Centre Groningen, Groningen, the Netherlands
Martin den Heijer
2Center of Expertise on Gender Dysphoria, Amsterdam UMC, Amsterdam, the Netherlands
6Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, The Netherlands
Odile A. van den Heuvel
7Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands
8Department of Anatomy and Neurosciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
9Amsterdam Neuroscience, Compulsivity Impulsivity and Attention, Amsterdam, The Netherlands
David Matthew Doyle
1Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands
2Center of Expertise on Gender Dysphoria, Amsterdam UMC, Amsterdam, the Netherlands
Birit F. P. Broekman
3Department of Psychiatry and Medical Psychology, OLVG Hospital, Amsterdam, the Netherlands
7Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands
10Amsterdam Public Health, Amsterdam, The Netherlands
Article usage
Posted August 28, 2024.
Changes in affect variability after starting gender-affirming hormone therapy
Margot W. L. Morssinkhof, Marijn Schipper, Baudewijntje P. C. Kreukels, Karin van der Tuuk, Martin den Heijer, Odile A. van den Heuvel, David Matthew Doyle, Birit F. P. Broekman
medRxiv 2024.08.28.24312697; doi: https://doi.org/10.1101/2024.08.28.24312697
Changes in affect variability after starting gender-affirming hormone therapy
Margot W. L. Morssinkhof, Marijn Schipper, Baudewijntje P. C. Kreukels, Karin van der Tuuk, Martin den Heijer, Odile A. van den Heuvel, David Matthew Doyle, Birit F. P. Broekman
medRxiv 2024.08.28.24312697; doi: https://doi.org/10.1101/2024.08.28.24312697
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2833)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12534)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2840)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)